Register Now: Engineering LNP's Beyond the Liver for Genetic Medicines

News
Multimedia
Publication
Conferences
Resources
Subscribe
Webcasts
Event Calendar

Spotlight -

Downstream Processing|

Upstream Processing

|Podcasts|April 26, 2018

Insights on Purity and Intactness of AAV Gene Therapy Vectors

Author(s)Vironova

Newsletter

Stay at the forefront of biopharmaceutical innovation. Subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Related Content

The BioPharm Brief: AI, T-Cell Engagers, and Longevity Research

ByFeliza Mirasol

September 15th 2026

The BioPharm Brief: Survival, Gene Editing, and Skin Cancer

ByEmily Schoenthaler

September 14th 2026

The BioPharm Brief: Cell Therapy, Capacity, and Contracts

ByEmily Schoenthaler

September 11th 2026

The BioPharm Brief: Delivery, Priority, and Gene Therapy

ByEmily Schoenthaler

September 10th 2026

Multiple multicolored viral capsid particles against a DNA double helix background. | Image Credit: © Dr_Microbe - stock.adobe.com

Encoded Therapeutics Raises $275M to Advance AAV Gene Therapy ETX101 for Dravet Syndrome

ByEmily Schoenthaler

September 10th 2026